Government news, all in one place
Government news, all in one place
The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.
Based on publicly published press releases (last 12 months)
840 articles
Showing 1-30
Monday, 11 May 2026
Updated safety advice has been issued to strengthen warnings about potential psychiatric and sexual dysfunction linked to finasteride and to provide p...
Monday, 11 May 2026
To future-proof the sector and ensure regulation keeps up with scientific and technological developments, the MHRA is consulting on proposed changes t...
Monday, 11 May 2026
New pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the GB market have been published....
Friday, 08 May 2026
The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in th...
Thursday, 07 May 2026
MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome ...
Thursday, 07 May 2026
MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema...
Thursday, 07 May 2026
MHRA and UK Border Force crack down on the illegal medicines trade in intensive 14-day international operation. ...
Friday, 01 May 2026
As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely....
Thursday, 30 April 2026
The MHRA has limited the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of five days due to side effects of...
Wednesday, 29 April 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) is pleased to announce the appointment of Jason Bonander as its new Chief Digital and T...
Wednesday, 29 April 2026
An MHRA-led investigation has exposed a £1.8 million illegal medicines and steroids network, leading to seven men being sentenced....
Tuesday, 28 April 2026
The MHRA?has?advised healthcare professionals to?stop supplying the affected?batch of Sertraline 100mg?and?return all remaining stock to their supplie...
Monday, 27 April 2026
Patients in the UK to get access to new treatments faster and still safely under new clinical trial regulations coming into force on 28 April 2026....
Thursday, 23 April 2026
Specific batches of Napralief 250mg Gastro?Resistant Tablets are being recalled because important safety and dosage information is missing from both t...
Wednesday, 22 April 2026
As with any medicine, the MHRA will keep the safety and effectiveness of Enflonsia under close review....
Monday, 20 April 2026
The MHRA?has?advised pharmacy and healthcare professionals to stop supplying the impacted batch and?return all remaining stock to their suppliers....
Wednesday, 15 April 2026
By Dame Jennifer Dixon...
Tuesday, 14 April 2026
As with any medicine, the MHRA will keep the safety and effectiveness of Wegovy under close review....
Monday, 13 April 2026
MHRA and eBay partnership removes 215 listings of potentially dangerous medicines from the eBay platform highlighting the benefits of private/public w...
Friday, 10 April 2026
New Access Work-Sharing Pathway for Priority Procedures....
Friday, 10 April 2026
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome ...
Wednesday, 08 April 2026
The MHRA continues to be at the forefront of innovation and secures multi-year funding to expand its pioneering AI Airlock programme....
Tuesday, 07 April 2026
The MHRA-led Access Consortium 2026 action plan will deepen collaboration, streamline work sharing, and speed up access to safe, high-quality medicine...
Thursday, 02 April 2026
The Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration are strengthening cooperation on medical device regula...
Thursday, 02 April 2026
As with any medicine, the MHRA will keep the safety and effectiveness of sevabertinib under close review. ...
Wednesday, 25 March 2026
Emerging technologies like AI and advanced therapies are transforming healthcare, and through international collaboration with partners such as Singap...
Tuesday, 24 March 2026
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants....
Tuesday, 24 March 2026
Medicines and Healthcare products Regulatory Agency (MHRA) takes decisive action to phase out animal testing by helping developers to make greater use...
Monday, 23 March 2026
As a precautionary measure, Mölnlycke Health Care is recalling three batches of Hibiwash, an antimicrobial wash, due to microbial contamination at the...
Tuesday, 17 March 2026
New pathway set to synchronise licensing and value assessment decisions...